In addition, high-fat diet or dyslipidemia in recipient of kidney graft could affect organ outcome identifying TSP-1 as a therapeutic target of interest and emphasizing the need to better control either cholesterol or OxLDL plasma levels in recipient at the early stage of renal transplantation. The gene discussed is THBS1; the disease is metabolic syndrome.